Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deglutition Disorders | 14 | 2023 | 297 | 3.880 |
Why?
|
| Manometry | 8 | 2020 | 276 | 2.330 |
Why?
|
| Deglutition | 8 | 2023 | 221 | 1.730 |
Why?
|
| Pharynx | 5 | 2019 | 89 | 1.590 |
Why?
|
| Esophageal Motility Disorders | 2 | 2016 | 59 | 0.980 |
Why?
|
| Spinal Diseases | 1 | 2023 | 53 | 0.870 |
Why?
|
| Laryngeal Nerves | 1 | 2021 | 5 | 0.830 |
Why?
|
| Triamcinolone | 1 | 2021 | 11 | 0.830 |
Why?
|
| Lidocaine | 1 | 2021 | 36 | 0.820 |
Why?
|
| Epinephrine | 1 | 2021 | 103 | 0.810 |
Why?
|
| Otolaryngology | 2 | 2019 | 38 | 0.800 |
Why?
|
| Cough | 1 | 2021 | 65 | 0.800 |
Why?
|
| Barium Sulfate | 3 | 2022 | 66 | 0.780 |
Why?
|
| Nerve Block | 1 | 2021 | 55 | 0.780 |
Why?
|
| Dysphonia | 1 | 2020 | 6 | 0.770 |
Why?
|
| Voice Disorders | 2 | 2020 | 22 | 0.760 |
Why?
|
| Voice | 1 | 2020 | 16 | 0.760 |
Why?
|
| Speech-Language Pathology | 1 | 2019 | 24 | 0.690 |
Why?
|
| Esophageal Sphincter, Upper | 2 | 2019 | 7 | 0.670 |
Why?
|
| Electric Impedance | 1 | 2019 | 131 | 0.660 |
Why?
|
| Biofeedback, Psychology | 1 | 2017 | 23 | 0.600 |
Why?
|
| Esophagitis | 1 | 2015 | 45 | 0.540 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 142 | 0.540 |
Why?
|
| Postoperative Complications | 2 | 2021 | 1615 | 0.480 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 166 | 0.480 |
Why?
|
| Bethanechol | 1 | 2013 | 11 | 0.470 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 17 | 0.470 |
Why?
|
| Diverticulum, Esophageal | 1 | 2012 | 4 | 0.430 |
Why?
|
| Contrast Media | 1 | 2016 | 594 | 0.430 |
Why?
|
| Esophageal Spasm, Diffuse | 1 | 2011 | 13 | 0.420 |
Why?
|
| Humans | 29 | 2023 | 68525 | 0.410 |
Why?
|
| Retrospective Studies | 9 | 2023 | 7264 | 0.380 |
Why?
|
| Middle Aged | 14 | 2021 | 21119 | 0.370 |
Why?
|
| Palate, Soft | 2 | 2019 | 12 | 0.340 |
Why?
|
| Tracheostomy | 2 | 2020 | 31 | 0.300 |
Why?
|
| Aged | 10 | 2021 | 14842 | 0.300 |
Why?
|
| Parotid Neoplasms | 1 | 2006 | 49 | 0.280 |
Why?
|
| Fluoroscopy | 3 | 2022 | 152 | 0.280 |
Why?
|
| Male | 15 | 2021 | 37281 | 0.270 |
Why?
|
| Female | 14 | 2021 | 38015 | 0.260 |
Why?
|
| Peristalsis | 2 | 2014 | 76 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 444 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 475 | 0.230 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 4843 | 0.230 |
Why?
|
| Consensus | 2 | 2022 | 211 | 0.210 |
Why?
|
| Adult | 10 | 2022 | 21375 | 0.210 |
Why?
|
| Zenker Diverticulum | 1 | 2021 | 7 | 0.200 |
Why?
|
| Myotomy | 1 | 2021 | 14 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2021 | 83 | 0.200 |
Why?
|
| Sialorrhea | 1 | 2020 | 7 | 0.190 |
Why?
|
| Voice Quality | 1 | 2020 | 21 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2023 | 1548 | 0.190 |
Why?
|
| Botulinum Toxins | 1 | 2020 | 18 | 0.190 |
Why?
|
| Esophagoscopy | 2 | 2021 | 72 | 0.190 |
Why?
|
| Goals | 1 | 2020 | 65 | 0.190 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 22 | 0.190 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 18 | 0.180 |
Why?
|
| Glucocorticoids | 1 | 2021 | 222 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2020 | 84 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2019 | 62 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.170 |
Why?
|
| Reference Standards | 1 | 2019 | 115 | 0.170 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2020 | 98 | 0.170 |
Why?
|
| Benchmarking | 1 | 2019 | 91 | 0.170 |
Why?
|
| Endoscopy | 2 | 2012 | 464 | 0.170 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.170 |
Why?
|
| Uvula | 1 | 2018 | 5 | 0.160 |
Why?
|
| Time | 1 | 2018 | 57 | 0.160 |
Why?
|
| Sensation | 1 | 2018 | 49 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 624 | 0.140 |
Why?
|
| Incidence | 2 | 2018 | 1582 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 346 | 0.140 |
Why?
|
| Adolescent | 3 | 2020 | 8903 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 2 | 2016 | 561 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 55 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2016 | 46 | 0.140 |
Why?
|
| Catheter Ablation | 1 | 2018 | 229 | 0.130 |
Why?
|
| Esophageal Neoplasms | 1 | 2016 | 150 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 78 | 0.120 |
Why?
|
| Administration, Topical | 1 | 2013 | 111 | 0.120 |
Why?
|
| Comorbidity | 1 | 2018 | 1425 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 1753 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2014 | 86 | 0.110 |
Why?
|
| Pressure | 1 | 2014 | 252 | 0.110 |
Why?
|
| Vital Signs | 1 | 2012 | 19 | 0.110 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2012 | 14 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2022 | 2356 | 0.110 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2012 | 33 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 53 | 0.110 |
Why?
|
| Picornaviridae Infections | 1 | 2012 | 2 | 0.110 |
Why?
|
| Pyroglyphidae | 1 | 2012 | 2 | 0.110 |
Why?
|
| Rhinovirus | 1 | 2012 | 15 | 0.110 |
Why?
|
| Pharyngeal Muscles | 1 | 2012 | 10 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2021 | 3702 | 0.110 |
Why?
|
| Allergens | 1 | 2012 | 54 | 0.110 |
Why?
|
| Barium | 2 | 2022 | 52 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 91 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1515 | 0.100 |
Why?
|
| Telemedicine | 1 | 2020 | 699 | 0.100 |
Why?
|
| Palliative Care | 1 | 2014 | 271 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 78 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 137 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2021 | 7028 | 0.100 |
Why?
|
| South Carolina | 1 | 2018 | 2750 | 0.100 |
Why?
|
| Stents | 1 | 2014 | 657 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2013 | 1341 | 0.090 |
Why?
|
| Young Adult | 2 | 2018 | 5708 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 5719 | 0.080 |
Why?
|
| Asthma | 1 | 2012 | 345 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3256 | 0.070 |
Why?
|
| Parotid Gland | 1 | 2006 | 33 | 0.070 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2006 | 76 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 125 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2006 | 94 | 0.070 |
Why?
|
| Risk | 2 | 2020 | 563 | 0.070 |
Why?
|
| Neck Injuries | 1 | 2005 | 17 | 0.070 |
Why?
|
| Larynx | 1 | 2005 | 49 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 306 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1139 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 508 | 0.050 |
Why?
|
| Pathologists | 1 | 2020 | 10 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 79 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2020 | 172 | 0.040 |
Why?
|
| Speech | 1 | 2020 | 118 | 0.040 |
Why?
|
| Child | 3 | 2020 | 6400 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2323 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2264 | 0.030 |
Why?
|
| SEER Program | 1 | 2016 | 150 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2453 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 799 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 41 | 0.030 |
Why?
|
| Exhalation | 1 | 2012 | 7 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2012 | 35 | 0.030 |
Why?
|
| Epitopes | 1 | 2012 | 146 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2012 | 185 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2012 | 382 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1860 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2006 | 122 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 306 | 0.020 |
Why?
|
| Tracheotomy | 1 | 2005 | 17 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2005 | 49 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2006 | 737 | 0.020 |
Why?
|
| United States | 1 | 2016 | 7335 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 3185 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 4655 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 20877 | 0.010 |
Why?
|